Prescient Therapeutics Limited (AU:PTX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Prescient Therapeutics Limited’s 2024 Annual General Meeting saw the approval of key resolutions, including the election of Dr. Gavin Shepherd and Dr. James Campbell as directors, and the issuance of options to Dr. Shepherd. However, the proposal for a 10% placement facility was not carried, showcasing a significant shareholder dissent.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.